165 related articles for article (PubMed ID: 2539163)
1. Pyrrolo[2,3-d]pyrimidines as inhibitors of cAMP-phosphodiesterase. Structure-activity relationship.
Klumpp S; Frey M; Kleefeld G; Sauer A; Eger K
Biochem Pharmacol; 1989 Mar; 38(6):949-53. PubMed ID: 2539163
[TBL] [Abstract][Full Text] [Related]
2. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
Torphy TJ; Cieslinski LB
Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of a high affinity type IV cyclic AMP phosphodiesterase in bovine trachealis by AH 21-132. Relevance to the spasmolytic and anti-spasmogenic actions of AH 21-132 in the intact tissue.
Giembycz MA; Barnes PJ
Biochem Pharmacol; 1991 Jul; 42(3):663-77. PubMed ID: 1650218
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes by deprenyl.
Kakkar R; Raju RV; Rajput AH; Sharma RK
Life Sci; 1996; 59(21):PL337-41. PubMed ID: 8937512
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the different cyclic nucleotide phosphodiesterase isoforms separated from rat brain by flavonoid compounds.
Picq M; Dubois M; Prigent AF; Némoz G; Pacheco H
Biochem Int; 1989 Jan; 18(1):47-57. PubMed ID: 2541724
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
Ko WC; Shih CM; Lai YH; Chen JH; Huang HL
Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679
[TBL] [Abstract][Full Text] [Related]
7. KS-505a, an isoform-selective inhibitor of calmodulin-dependent cyclic nucleotide phosphodiesterase.
Ichimura M; Eiki R; Osawa K; Nakanishi S; Kase H
Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):311-6. PubMed ID: 8645223
[TBL] [Abstract][Full Text] [Related]
8. The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages.
Turner NC; Wood LJ; Burns FM; Gueremy T; Souness JE
Br J Pharmacol; 1993 Apr; 108(4):876-83. PubMed ID: 8387385
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta.
Lugnier C; Schoeffter P; Le Bec A; Strouthou E; Stoclet JC
Biochem Pharmacol; 1986 May; 35(10):1743-51. PubMed ID: 2423089
[TBL] [Abstract][Full Text] [Related]
10. Role of phosphodiesterase isoenzymes in regulating intracellular cyclic AMP in adenosine-stimulated smooth muscle cells.
Xiong Y; Westhead EW; Slakey LL
Biochem J; 1995 Jan; 305 ( Pt 2)(Pt 2):627-33. PubMed ID: 7832782
[TBL] [Abstract][Full Text] [Related]
11. Fused pyrimidine based inhibitors of phosphodiesterase 7 (PDE7): synthesis and initial structure-activity relationships.
Kempson J; Pitts WJ; Barbosa J; Guo J; Omotoso O; Watson A; Stebbins K; Starling GC; Dodd JH; Barrish JC; Felix R; Fischer K
Bioorg Med Chem Lett; 2005 Apr; 15(7):1829-33. PubMed ID: 15780616
[TBL] [Abstract][Full Text] [Related]
12. Potent tetracyclic guanine inhibitors of PDE1 and PDE5 cyclic guanosine monophosphate phosphodiesterases with oral antihypertensive activity.
Ahn HS; Bercovici A; Boykow G; Bronnenkant A; Chackalamannil S; Chow J; Cleven R; Cook J; Czarniecki M; Domalski C; Fawzi A; Green M; Gündes A; Ho G; Laudicina M; Lindo N; Ma K; Manna M; McKittrick B; Mirzai B; Nechuta T; Neustadt B; Puchalski C; Pula K; Zhang H
J Med Chem; 1997 Jul; 40(14):2196-210. PubMed ID: 9216839
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of polycyclic pyrazolo[3,4-d]pyrimidines as PDE1 and PDE5 cGMP phosphodiesterase inhibitors.
Xia Y; Chackalamannil S; Czarniecki M; Tsai H; Vaccaro H; Cleven R; Cook J; Fawzi A; Watkins R; Zhang H
J Med Chem; 1997 Dec; 40(26):4372-7. PubMed ID: 9435906
[TBL] [Abstract][Full Text] [Related]
14. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
Lavan BE; Lakey T; Houslay MD
Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of calmodulin-dependent cyclic AMP phosphodiesterase by phenoxazines.
Jagadeesh S; Padma T; Parimala H; Chandramouli KH; D'Souza CJ; Thimmaiah KN
Biochem Biophys Res Commun; 2006 Apr; 342(3):690-701. PubMed ID: 16494842
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of pig aortic smooth muscle cell DNA synthesis by selective type III and type IV cyclic AMP phosphodiesterase inhibitors.
Souness JE; Hassall GA; Parrott DP
Biochem Pharmacol; 1992 Sep; 44(5):857-66. PubMed ID: 1326964
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibitors of calmodulin-dependent phosphodiesterase and other enzymes.
Hidaka H; Inagaki M; Nishikawa M; Tanaka T
Methods Enzymol; 1988; 159():652-60. PubMed ID: 2842626
[No Abstract] [Full Text] [Related]
18. Effects of divalent metals on the specificity of inhibitors of the cyclic nucleotide phosphodiesterases from bovine heart.
Donnelly TE; Barron B
Biochim Biophys Acta; 1981 Jan; 657(1):168-78. PubMed ID: 6260197
[TBL] [Abstract][Full Text] [Related]
19. Antagonism of estrogen receptor and calmodulin association by antiestrogens is not dependent on an interaction with calmodulin.
Rowlands MG; Grimshaw R; Jarman M; Bouhoute A; Leclercq G
Biochem Pharmacol; 1997 Jan; 53(2):241-4. PubMed ID: 9037257
[TBL] [Abstract][Full Text] [Related]
20. Adenosine cyclic 3',5',-monophosphate phosphodiesterasr inhibitors. 2.3-Substituted 5,7-dialkylpyrazolo [1,5-a]pyrimidines.
Novinson T; Miller JP; Scholten M; Robins RK; Simon LN; O'Brien DE; Meyer RB
J Med Chem; 1975 May; 18(5):460-4. PubMed ID: 168380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
